Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7622116 Method of treating inflammation using soluble IL-17RCX4

Patent 7622116 was granted and assigned to ZymoGenetics on November, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rolf E. Kuestner0

Zeren Gao0

Mark W. Rixon0

Steven D. Levin0

Date of Patent

November 24, 2009

0

Patent Application Number

116730940

Date Filed

February 9, 2007

0

Patent Citations Received

US Patent 11788066 Antibody conjugates and methods of making and using the same

Patent Primary Examiner

Robert Landsman

0

Patent abstract

The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. IL-17RC is a common receptor for IL-17A and IL-17F. The present invention includes methods of using a soluble IL-17RC receptor, IL-17RCx4 for treating inflammation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7622116 Method of treating inflammation using soluble IL-17RCX4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.